Sichuan Huiyu Pharmaceutical Co Ltd (688553) — Cash Flow Reinvestment Rate
Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Cash Flow Reinvestment Rate of 0.52x as of September 2025, reinvesting CN¥30.63 Million (capex CN¥30.63 Million ) from operating cash flow of CN¥58.54 Million. Check cash flow quality index of Sichuan Huiyu Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sichuan Huiyu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Sichuan Huiyu Pharmaceutical Co Ltd across 7 annual periods. Explore how well can Sichuan Huiyu Pharmaceutical Co Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Sichuan Huiyu Pharmaceutical Co Ltd (2018–2024)
Year-by-year capital reinvestment analysis for Sichuan Huiyu Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 688553 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.17x | CN¥526.72 Million | CN¥242.96 Million | CN¥128.18 Million | ▼ -82.4% |
| 2023 | 12.35x | CN¥826.75 Million | CN¥66.93 Million | CN¥296.72 Million | ▲ +273.0% |
| 2022 | 3.31x | CN¥642.65 Million | CN¥194.06 Million | CN¥461.61 Million | ▼ -35.9% |
| 2021 | 5.17x | CN¥2.31 Billion | CN¥446.36 Million | CN¥433.45 Million | ▲ +421.4% |
| 2020 | 0.99x | CN¥384.33 Million | CN¥387.95 Million | CN¥158.24 Million | ▼ -16.9% |
| 2019 | 1.19x | CN¥388.90 Million | CN¥326.22 Million | CN¥110.00 Million | ▲ +567.8% |
| 2018 | 0.18x | CN¥23.04 Million | CN¥129.06 Million | CN¥23.04 Million | — |